Testing a Training Program to Enhance Emotional Management Skills and Professional Resiliency in Healthcare Providers
NCT ID: NCT02552264
Last Updated: 2024-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2020-11-01
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Life Coaching Intervention on the Well-being and Distress of Physicians
NCT05149911
Leading Well-being and the Psychosocial Working Environment - A Cluster-randomized Waitlist Controlled Trial
NCT05623371
The Impact of a Novel Coaching Program on Medical Errors and Well-Being of Physicians
NCT05557981
Autonomic Modulation Training for Police Exposed to Post-Traumatic Stress Injuries
NCT05521360
Better Together Physician Coaching: An Innovative Solution to Medical Trainee Burnout
NCT05222685
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Acceptance and Commitment Therapy for the Workplace program (ACT-W) is an evidence-based program designed to help individuals manage emotions and stress by learning skills to accept negative feelings, thoughts, and sensations and to move toward valued behaviours (Flaxman, Bond, Livheim, Hayes, 2013). The ACT-W program has been shown to increase the ability to manage emotions and stress (Flaxman \& Bond, 2010) and to increase the ability to learn new behaviours (Bond \& Flaxman, 2006; Luoma et al., 2007; Varra, Hayes et al., 2008).
The purpose of this project is to evaluate the implementation of the ACT-W training program for healthcare providers through the BCI.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate intervention
Acceptance and Commitment Therapy
Acceptance and Commitment Therapy for the Workplace
Acceptance and Commitment Therapy
Waitlist control
Acceptance and Commitment Therapy
Acceptance and Commitment Therapy for the Workplace
Acceptance and Commitment Therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acceptance and Commitment Therapy for the Workplace
Acceptance and Commitment Therapy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IWK Health Centre
OTHER
Nova Scotia Health Authority
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dayna Lee-Baggley, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Nova Scotia Health Authority
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nova Scotia Health Authority
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NSHA REB ROMEO File #: 1019748
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.